Lessons learned from marketed and investigational prodrugs

被引：281

作者：

Ettmayer, P

Amidon, GL

Clement, B

Testa, B

机构：

[1] Novartis Inst BioMed Res, A-1235 Vienna, Austria

[2] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA

[3] Univ Kiel, Inst Pharmaceut, D-24118 Kiel, Germany

[4] CHU Vaudois, Dept Pharm, CH-1011 Lausanne, Switzerland

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2004年 / 47卷 / 10期

关键词：

D O I：

10.1021/jm0303812

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：2393 / 2404

页数：12

共 86 条

[1] CHEMICAL ASPECTS OF SELECTIVE TOXICITY [J].

ALBERT, A .

NATURE, 1958, 182 (4633) :421-423

[2]

[Anonymous], 2003, HYDROLYSIS DRUG PROD

[3] AMINO-ACID ESTER PRODRUGS OF ACYCLOVIR [J].

BEAUCHAMP, LM ;

ORR, GF ;

DEMIRANDA, P ;

BURNETTE, T ;

KRENITSKY, TA .

ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1992, 3 (03) :157-164

[4] Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: Challenges to the discovery scientist [J].

Beaumont, K ;

Webster, R ;

Gardner, I ;

Dack, K .

CURRENT DRUG METABOLISM, 2003, 4 (06) :461-485

[5] Exploring the mechanistic aspects of mitomycin antibiotic bioactivation in Chinese hamster ovary cells overexpressing NADPH:cytochrome C (P-450) reductase and DT-diaphorase [J].

Belcourt, MF ;

Hodnick, WF ;

Rockwell, S ;

Sartorelli, AC .

ADVANCES IN ENZYME REGULATION, VOL 38, 1998, 38 :111-133

[6] ESMOLOL - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY [J].

BENFIELD, P ;

SORKIN, EM .

DRUGS, 1987, 33 (04) :392-412

[7] Barriers to remember: brain-targeting chemical delivery systems and Alzheimer's disease [J].

Bodor, N ;

Buchwald, P .

DRUG DISCOVERY TODAY, 2002, 7 (14) :766-774

[8]

Bodor N, 2001, PHARMAZIE, V56, pS67

[9]

Bodor N, 2000, MED RES REV, V20, P58, DOI 10.1002/(SICI)1098-1128(200001)20:1<58::AID-MED3>3.0.CO

[10]

2-X

← 1 2 3 4 5 6 7 8 9 →